DZHK-Studie DEDICATE-DZHK6

Short information

The TOMAHAWK trial is a prospective, randomized, multi-center study which is supported by the German Center for Cardiovascular Research (DZHK). The trial was initiated at the DZHK site Hamburg/Kiel/Lübeck by Prof. Dr. med. Steffen Desch and Prof. Dr. med. Holger Thiele from the University Heart Center Lübeck.

Current stage

Currently, the trial is in the final planing stage. Patient randomization will start in October 2016.